[Form 4] AKAMAI TECHNOLOGIES INC Insider Trading Activity

Rhea-AI Filing Summary

Akamai Technologies executive Daniel Joseph reported a planned stock sale under a Rule 10b5-1 trading plan. On 11/17/2025, he sold 5,000 shares of Akamai common stock at a weighted average price of $87.6902, with individual trade prices ranging from $87.33 to $87.95. After this transaction, he beneficially owned 22,349 shares directly and 102.25 shares indirectly through a 401(k) plan, with the 401(k) balance reported as of November 14, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Joseph Paul C

(Last) (First) (Middle)

C/O AKAMAI TECHNOLOGIES, INC.

145 BROADWAY

(Street)

CAMBRIDGE MA 02142

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AKAMAI TECHNOLOGIES INC [ AKAM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP - Global Sales

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/17/2025		S(1)		5,000	D	$87.6902(2)	22,349	D
Common Stock								102.25(3)	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sale was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Joseph on March 17, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.33 to $87.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. As of November 14, 2025.

Remarks:

	/s/ Thomas M. Lair, as power of attorney	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Akamai Technologies (AKAM) report in this Form 4?

The filing reports that executive officer Daniel Joseph, EVP - Global Sales, sold 5,000 shares of Akamai common stock on 11/17/2025.

At what price were the 5,000 Akamai (AKAM) shares sold by the EVP?

The 5,000 shares were sold at a weighted average price of $87.6902 per share, with individual trades executed between $87.33 and $87.95.

Was the Akamai (AKAM) insider sale made under a Rule 10b5-1 plan?

Yes. The sale was made under a Rule 10b5-1 trading plan adopted by Mr. Joseph on March 17, 2025.

How many Akamai (AKAM) shares does the reporting person own after the sale?

After the reported transaction, Mr. Joseph beneficially owned 22,349 shares of Akamai common stock directly and 102.25 shares indirectly through a 401(k) plan.

What is the reporting person’s role at Akamai Technologies (AKAM)?

The reporting person is an officer of Akamai Technologies, serving as EVP - Global Sales.

Is this Akamai (AKAM) Form 4 filed by more than one reporting person?

No. The filing states that the Form is filed by one reporting person.

Can investors obtain detailed pricing for each Akamai (AKAM) trade in this Form 4?

Yes. The reporting person undertakes to provide the issuer, any security holder, or SEC staff full information on the number of shares sold at each separate price within the $87.33–$87.95 range upon request.